<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>LIB003 (Lerodalcibep) - Leaf Intelligence Analysis</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <style>
        /* Custom animations */
        @keyframes fadeInRow {
            from { opacity: 0; transform: translateY(10px); }
            to { opacity: 1; transform: translateY(0); }
        }
        @keyframes pulse {
            0%, 100% { opacity: 0.5; transform: scale(0.95); }
            50% { opacity: 0.8; transform: scale(1.1); }
        }
        @keyframes slideIn {
            from { opacity: 0; transform: translateX(-10px); }
            to { opacity: 1; transform: translateX(0); }
        }
        .animate-fade-in-row { animation: fadeInRow 0.3s ease forwards; }
        .animate-pulse-glow { animation: pulse 3s ease-in-out infinite; }
        .animate-slide-in { animation: slideIn 0.6s ease-out forwards; }
        
        /* Staggered animations */
        .stagger-1 { animation-delay: 0.1s; }
        .stagger-2 { animation-delay: 0.2s; }
        .stagger-3 { animation-delay: 0.3s; }
        .stagger-4 { animation-delay: 0.4s; }
        .stagger-5 { animation-delay: 0.5s; }
        
        /* Custom scrollbar */
        ::-webkit-scrollbar { width: 8px; height: 8px; }
        ::-webkit-scrollbar-track { @apply bg-gray-100 dark:bg-gray-800 rounded; }
        ::-webkit-scrollbar-thumb { @apply bg-gray-400 dark:bg-gray-600 rounded hover:bg-gray-500 dark:hover:bg-gray-500; }
        
        /* Glass effect */
        .glass {
            background: rgba(255, 255, 255, 0.75);
            backdrop-filter: blur(20px);
            -webkit-backdrop-filter: blur(20px);
        }
        .dark .glass {
            background: rgba(17, 24, 39, 0.75);
        }
    </style>
</head>
<body class="bg-gray-50 dark:bg-gray-900 transition-all duration-300">
    <!-- Fixed Header -->
    <header class="fixed top-0 left-0 right-0 z-50 glass border-b border-gray-200 dark:border-gray-700 shadow-lg">
        <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
            <div class="flex justify-between items-center py-4">
                <!-- Logo -->
                <div class="flex items-center space-x-3">
                    <div class="relative">
                        <img src="leaf.png" alt="Leaf Intelligence" class="h-12 w-12 relative z-10">
                        <div class="absolute inset-0 bg-gradient-to-r from-green-400 to-cyan-400 opacity-20 blur-xl animate-pulse-glow"></div>
                    </div>
                    <div>
                        <div class="text-xl font-light bg-gradient-to-r from-green-600 to-cyan-600 dark:from-green-400 dark:to-cyan-400 bg-clip-text text-transparent">
                            Leaf Intelligence
                        </div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 font-light">
                            Cholesterol Therapies Analysis
                        </div>
                    </div>
                </div>

                <!-- Navigation -->
                <nav class="hidden md:flex items-center space-x-1 bg-gray-100/50 dark:bg-gray-800/50 p-1.5 rounded-lg backdrop-blur-sm">
                    <a href="index.html" class="px-5 py-2 rounded-md text-sm font-medium transition-all duration-200 text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white hover:bg-white/50 dark:hover:bg-gray-700/50">
                        Overview
                    </a>
                    <a href="approved.html" class="px-5 py-2 rounded-md text-sm font-medium transition-all duration-200 text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white hover:bg-white/50 dark:hover:bg-gray-700/50">
                        Competitors
                    </a>
                    <a href="comparison.html" class="px-5 py-2 rounded-md text-sm font-medium transition-all duration-200 text-gray-600 dark:text-gray-400 hover:text-gray-900 dark:hover:text-white hover:bg-white/50 dark:hover:bg-gray-700/50">
                        Comparison
                    </a>
                </nav>

                <!-- Theme Toggle -->
                <!-- <button onclick="toggleTheme()" class="relative w-14 h-7 rounded-full bg-gray-200 dark:bg-gray-700 transition-all duration-300 shadow-inner hover:shadow-md">
                    <div class="absolute top-0.5 left-0.5 w-6 h-6 rounded-full bg-white dark:bg-gray-900 shadow-lg transform transition-transform duration-300 dark:translate-x-7 flex items-center justify-center">
                        <svg class="w-4 h-4 text-yellow-500 dark:hidden" fill="currentColor" viewBox="0 0 24 24">
                            <path d="M12 7a5 5 0 100 10 5 5 0 000-10z"/>
                        </svg>
                        <svg class="w-4 h-4 text-indigo-400 hidden dark:block" fill="currentColor" viewBox="0 0 24 24">
                            <path d="M21 12.79A9 9 0 1111.21 3 7 7 0 0021 12.79z"/>
                        </svg>
                    </div>
                </button> -->
            </div>
        </div>
    </header>

    <!-- Main Container with padding for fixed header -->
    <div class="pt-20 min-h-screen">
        <div class="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8 py-8">
            
            <!-- Drug Header -->
            <div class="glass rounded-2xl p-8 mb-8 border border-gray-200 dark:border-gray-700">
                <div class="flex justify-between items-start">
                    <div>
                        <h1 class="text-4xl font-light mb-2 text-gray-900 dark:text-white">
                            LIB003 (Lerodalcibep)
                        </h1>
                        <p class="text-lg text-gray-600 dark:text-gray-400 mb-4">
                            Third-Generation PCSK9 Inhibitor â€¢ LIB Therapeutics
                        </p>
                        <div class="flex flex-wrap gap-2">
                            <span class="inline-flex items-center px-3 py-1 rounded-full text-xs font-medium bg-amber-100 dark:bg-amber-900/30 text-amber-800 dark:text-amber-400">
                                Phase 3 Complete
                            </span>
                            <span class="inline-flex items-center px-3 py-1 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">
                                FDA Fast Track
                            </span>
                            <span class="inline-flex items-center px-3 py-1 rounded-full text-xs font-medium bg-blue-100 dark:bg-blue-900/30 text-blue-800 dark:text-blue-400">
                                Filing 2024-2025
                            </span>
                        </div>
                    </div>
                    <div class="flex gap-2">
                        <a href="https://www.libtherapeutics.com/pipeline/lib003/" target="_blank" class="inline-flex items-center px-4 py-2 text-sm font-medium rounded-lg bg-gradient-to-r from-indigo-600 to-purple-600 text-white hover:from-indigo-700 hover:to-purple-700 transition-all">
                            Company Page
                        </a>
                        <a href="https://clinicaltrials.gov/search?term=lerodalcibep" target="_blank" class="inline-flex items-center px-4 py-2 text-sm font-medium rounded-lg border border-gray-300 dark:border-gray-600 text-gray-700 dark:text-gray-300 hover:bg-gray-50 dark:hover:bg-gray-800 transition-all">
                            Clinical Trials
                        </a>
                    </div>
                </div>
            </div>

            <!-- Tabs Navigation -->
            <div class="glass rounded-xl p-2 mb-6 border border-gray-200 dark:border-gray-700">
                <div class="flex gap-2 overflow-x-auto">
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all bg-white dark:bg-gray-800 text-indigo-600 dark:text-indigo-400 shadow-md" onclick="showTab('overview')">
                        Overview
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:bg-gray-100 dark:hover:bg-gray-800" onclick="showTab('mechanism')">
                        Mechanism
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:bg-gray-100 dark:hover:bg-gray-800" onclick="showTab('clinical')">
                        Clinical Data
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:bg-gray-100 dark:hover:bg-gray-800" onclick="showTab('safety')">
                        Safety
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:bg-gray-100 dark:hover:bg-gray-800" onclick="showTab('regulatory')">
                        Regulatory
                    </button>
                    <button class="tab-btn px-6 py-3 rounded-lg text-sm font-medium transition-all text-gray-600 dark:text-gray-400 hover:bg-gray-100 dark:hover:bg-gray-800" onclick="showTab('commercial')">
                        Commercial
                    </button>
                </div>
            </div>

            <!-- Overview Tab -->
            <div id="overview" class="tab-content">
                <!-- Key Metrics Grid -->
                <div class="grid grid-cols-1 lg:grid-cols-3 gap-6 mb-8">
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="flex items-center gap-2 mb-4 text-lg font-light text-gray-900 dark:text-white">
                            <span class="text-2xl">ðŸ”¬</span> Innovation Profile
                        </h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">â€¢</span>
                                Novel adnectin-albumin fusion protein
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">â€¢</span>
                                Smaller than mAbs (~1.2 mL injection)
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">â€¢</span>
                                Once-monthly dosing (12 injections/year)
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">â€¢</span>
                                No immunogenicity over 52 weeks
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2">â€¢</span>
                                FDA Fast Track designation
                            </li>
                        </ul>
                    </div>

                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="flex items-center gap-2 mb-4 text-lg font-light text-gray-900 dark:text-white">
                            <span class="text-2xl">ðŸ“Š</span> Clinical Performance
                        </h3>
                        <div class="space-y-3">
                            <div>
                                <div class="flex justify-between mb-1">
                                    <span class="text-xs text-gray-600 dark:text-gray-400">LDL Reduction</span>
                                    <span class="text-xs font-medium text-gray-900 dark:text-white">56%</span>
                                </div>
                                <div class="w-full bg-gray-200 dark:bg-gray-700 rounded-full h-2">
                                    <div class="bg-gradient-to-r from-indigo-500 to-purple-500 h-2 rounded-full" style="width: 56%"></div>
                                </div>
                            </div>
                            <div>
                                <div class="flex justify-between mb-1">
                                    <span class="text-xs text-gray-600 dark:text-gray-400">Peak Efficacy</span>
                                    <span class="text-xs font-medium text-gray-900 dark:text-white">70%</span>
                                </div>
                                <div class="w-full bg-gray-200 dark:bg-gray-700 rounded-full h-2">
                                    <div class="bg-gradient-to-r from-indigo-500 to-purple-500 h-2 rounded-full" style="width: 70%"></div>
                                </div>
                            </div>
                            <div>
                                <div class="flex justify-between mb-1">
                                    <span class="text-xs text-gray-600 dark:text-gray-400">Goal Achievement</span>
                                    <span class="text-xs font-medium text-gray-900 dark:text-white">90%+</span>
                                </div>
                                <div class="w-full bg-gray-200 dark:bg-gray-700 rounded-full h-2">
                                    <div class="bg-gradient-to-r from-green-500 to-emerald-500 h-2 rounded-full" style="width: 90%"></div>
                                </div>
                            </div>
                        </div>
                        <div class="mt-4 flex gap-2">
                            <a href="https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/03/02/05/14/liberate-hr" target="_blank" class="text-xs text-indigo-600 dark:text-indigo-400 hover:underline">
                                View ACC 2024 Data â†’
                            </a>
                        </div>
                    </div>

                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="flex items-center gap-2 mb-4 text-lg font-light text-gray-900 dark:text-white">
                            <span class="text-2xl">ðŸŽ¯</span> Market Position
                        </h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">â€¢</span>
                                Bridge between Q2W mAbs and biannual inclisiran
                            </li>
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">â€¢</span>
                                Potential for self-administration
                            </li>
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">â€¢</span>
                                Pharmacy benefit eligible
                            </li>
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">â€¢</span>
                                Expected pricing ~20% below mAbs
                            </li>
                            <li class="flex items-start">
                                <span class="text-blue-500 mr-2">â€¢</span>
                                Patent protection to late 2030s
                            </li>
                        </ul>
                    </div>
                </div>

                <!-- Dosing Comparison -->
                <div class="glass rounded-xl p-6 mb-8 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-xl font-light mb-6 text-gray-900 dark:text-white">Dosing Frequency Comparison</h3>
                    <div class="grid grid-cols-2 md:grid-cols-4 gap-4">
                        <div class="p-4 bg-white dark:bg-gray-800 rounded-lg border border-gray-200 dark:border-gray-700 hover:shadow-md transition-shadow">
                            <div class="text-2xl font-bold text-gray-600 dark:text-gray-400">Q2W</div>
                            <div class="text-sm font-medium text-gray-900 dark:text-white mt-1">Repatha/Praluent</div>
                            <div class="text-xs text-gray-500 dark:text-gray-400 mt-1">26 injections/year</div>
                        </div>
                        <div class="p-4 bg-gradient-to-r from-indigo-50 to-purple-50 dark:from-indigo-900/20 dark:to-purple-900/20 rounded-lg border-2 border-indigo-500 shadow-md">
                            <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">Monthly</div>
                            <div class="text-sm font-medium text-gray-900 dark:text-white mt-1">LIB003</div>
                            <div class="text-xs text-gray-500 dark:text-gray-400 mt-1">12 injections/year</div>
                        </div>
                        <div class="p-4 bg-white dark:bg-gray-800 rounded-lg border border-gray-200 dark:border-gray-700 hover:shadow-md transition-shadow">
                            <div class="text-2xl font-bold text-gray-600 dark:text-gray-400">Q4W</div>
                            <div class="text-sm font-medium text-gray-900 dark:text-white mt-1">Praluent Option</div>
                            <div class="text-xs text-gray-500 dark:text-gray-400 mt-1">12 injections/year</div>
                        </div>
                        <div class="p-4 bg-white dark:bg-gray-800 rounded-lg border border-gray-200 dark:border-gray-700 hover:shadow-md transition-shadow">
                            <div class="text-2xl font-bold text-gray-600 dark:text-gray-400">Q6M</div>
                            <div class="text-sm font-medium text-gray-900 dark:text-white mt-1">Inclisiran</div>
                            <div class="text-xs text-gray-500 dark:text-gray-400 mt-1">2 injections/year</div>
                        </div>
                    </div>
                </div>

                <!-- Key Differentiation -->
                <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-lg font-light mb-4 text-gray-900 dark:text-white">Key Differentiation</h3>
                    <p class="text-sm text-gray-600 dark:text-gray-400 leading-relaxed">
                        LIB003 represents a "third-generation" approach to PCSK9 inhibition, using novel adnectin technology 
                        rather than traditional antibodies. Its monthly dosing offers a sweet spot between frequent mAb injections 
                        and very infrequent inclisiran dosing, potentially improving adherence while maintaining consistent LDL control. 
                        The smaller injection volume (1.2 mL) and lack of immunogenicity over 52 weeks demonstrate the success of 
                        its engineered protein design.
                    </p>
                    <div class="mt-4">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/?term=lerodalcibep" target="_blank" class="text-sm text-indigo-600 dark:text-indigo-400 hover:underline">
                            View PubMed Publications â†’
                        </a>
                    </div>
                </div>
            </div>

            <!-- Mechanism Tab -->
            <div id="mechanism" class="tab-content hidden">
                <div class="glass rounded-xl p-6 mb-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-xl font-light mb-4 text-gray-900 dark:text-white">Mechanism of Action</h3>
                    <div class="grid grid-cols-1 lg:grid-cols-2 gap-6">
                        <div>
                            <h4 class="text-lg font-medium mb-3 text-gray-800 dark:text-gray-200">Novel Technology</h4>
                            <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                                <li><strong>Adnectin component:</strong> Small engineered protein based on fibronectin that specifically binds PCSK9</li>
                                <li><strong>Albumin fusion:</strong> Extends half-life to enable monthly dosing</li>
                                <li><strong>Smaller size:</strong> Being smaller than mAbs allows for highly concentrated, low-volume injections</li>
                                <li><strong>Same endpoint:</strong> Prevents PCSK9 from degrading LDL receptors, increasing LDL clearance</li>
                            </ul>
                        </div>
                        <div>
                            <h4 class="text-lg font-medium mb-3 text-gray-800 dark:text-gray-200">Dosing Specifications</h4>
                            <div class="grid grid-cols-2 gap-4">
                                <div class="p-3 bg-gray-50 dark:bg-gray-800 rounded-lg">
                                    <div class="text-xs text-gray-600 dark:text-gray-400">Dose</div>
                                    <div class="text-xl font-bold text-indigo-600 dark:text-indigo-400">300 mg</div>
                                </div>
                                <div class="p-3 bg-gray-50 dark:bg-gray-800 rounded-lg">
                                    <div class="text-xs text-gray-600 dark:text-gray-400">Frequency</div>
                                    <div class="text-xl font-bold text-indigo-600 dark:text-indigo-400">Monthly</div>
                                </div>
                                <div class="p-3 bg-gray-50 dark:bg-gray-800 rounded-lg">
                                    <div class="text-xs text-gray-600 dark:text-gray-400">Volume</div>
                                    <div class="text-xl font-bold text-indigo-600 dark:text-indigo-400">1.2 mL</div>
                                </div>
                                <div class="p-3 bg-gray-50 dark:bg-gray-800 rounded-lg">
                                    <div class="text-xs text-gray-600 dark:text-gray-400">Annual Injections</div>
                                    <div class="text-xl font-bold text-indigo-600 dark:text-indigo-400">12</div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Clinical Data Tab -->
            <div id="clinical" class="tab-content hidden">
                <div class="glass rounded-xl overflow-hidden border border-gray-200 dark:border-gray-700 mb-6">
                    <div class="overflow-x-auto">
                        <table class="w-full">
                            <thead class="bg-gray-50 dark:bg-gray-800 border-b border-gray-200 dark:border-gray-700">
                                <tr>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Trial</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Phase</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">N</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Duration</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Key Results</th>
                                    <th class="px-6 py-4 text-left text-xs font-medium text-gray-700 dark:text-gray-300 uppercase tracking-wider">Actions</th>
                                </tr>
                            </thead>
                            <tbody class="divide-y divide-gray-200 dark:divide-gray-700">
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4">
                                        <div class="text-sm font-medium text-gray-900 dark:text-white">LIBerate-HR</div>
                                        <div class="text-xs text-gray-500">2023-2024</div>
                                    </td>
                                    <td class="px-6 py-4">
                                        <span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">
                                            Phase 3
                                        </span>
                                    </td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">922</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">52 weeks</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">
                                        56% LDL reduction<br>
                                        >90% achieved goals
                                    </td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/study/NCT04927429" target="_blank" class="text-xs text-indigo-600 dark:text-indigo-400 hover:underline">
                                            View Trial â†’
                                        </a>
                                    </td>
                                </tr>
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4">
                                        <div class="text-sm font-medium text-gray-900 dark:text-white">LIBerate-FH</div>
                                        <div class="text-xs text-gray-500">2023-2024</div>
                                    </td>
                                    <td class="px-6 py-4">
                                        <span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-green-100 dark:bg-green-900/30 text-green-800 dark:text-green-400">
                                            Phase 3
                                        </span>
                                    </td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">~450</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">24 weeks</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">
                                        Similar efficacy<br>
                                        Well-tolerated
                                    </td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/search?term=LIBerate-FH" target="_blank" class="text-xs text-indigo-600 dark:text-indigo-400 hover:underline">
                                            View Trial â†’
                                        </a>
                                    </td>
                                </tr>
                                <tr class="hover:bg-gray-50 dark:hover:bg-gray-800 transition-colors">
                                    <td class="px-6 py-4">
                                        <div class="text-sm font-medium text-gray-900 dark:text-white">HoFH Study</div>
                                        <div class="text-xs text-gray-500">Interim data</div>
                                    </td>
                                    <td class="px-6 py-4">
                                        <span class="inline-flex items-center px-2.5 py-0.5 rounded-full text-xs font-medium bg-amber-100 dark:bg-amber-900/30 text-amber-800 dark:text-amber-400">
                                            Phase 3
                                        </span>
                                    </td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">~60</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">24 weeks</td>
                                    <td class="px-6 py-4 text-sm text-gray-600 dark:text-gray-400">
                                        ~10% LDL reduction<br>
                                        (Meaningful in HoFH)
                                    </td>
                                    <td class="px-6 py-4">
                                        <a href="https://clinicaltrials.gov/search?term=lerodalcibep+HoFH" target="_blank" class="text-xs text-indigo-600 dark:text-indigo-400 hover:underline">
                                            View Trial â†’
                                        </a>
                                    </td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>

                <!-- Efficacy Chart -->
                <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-lg font-light mb-4 text-gray-900 dark:text-white">LDL-C Reduction Comparison</h3>
                    <div class="grid grid-cols-3 md:grid-cols-5 gap-4">
                        <div class="text-center">
                            <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">70%</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">Phase 2<br>Peak Effect</div>
                        </div>
                        <div class="text-center">
                            <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">62%</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">LIBerate-HR<br>24 weeks</div>
                        </div>
                        <div class="text-center">
                            <div class="text-2xl font-bold text-indigo-600 dark:text-indigo-400">56%</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">LIBerate-HR<br>52 weeks</div>
                        </div>
                        <div class="text-center">
                            <div class="text-2xl font-bold text-amber-600 dark:text-amber-400">60%</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">Repatha<br>Typical</div>
                        </div>
                        <div class="text-center">
                            <div class="text-2xl font-bold text-amber-600 dark:text-amber-400">50%</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400 mt-1">Inclisiran<br>Typical</div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- Safety Tab -->
            <div id="safety" class="tab-content hidden">
                <div class="grid grid-cols-2 md:grid-cols-3 gap-4 mb-6">
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-3xl font-bold text-green-600 dark:text-green-400">0%</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-2">Immunogenicity<br>Over 52 Weeks</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-3xl font-bold text-green-600 dark:text-green-400">Similar</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-2">AE Rate<br>vs Placebo</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-3xl font-bold text-green-600 dark:text-green-400">0</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-2">Treatment-Related<br>Serious AEs</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-3xl font-bold text-green-600 dark:text-green-400">None</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-2">Liver/CK<br>Elevations</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-3xl font-bold text-green-600 dark:text-green-400">None</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-2">Neurocognitive<br>Effects</div>
                    </div>
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700 text-center">
                        <div class="text-3xl font-bold text-green-600 dark:text-green-400">Low</div>
                        <div class="text-xs text-gray-600 dark:text-gray-400 mt-2">Injection Site<br>Reactions</div>
                    </div>
                </div>

                <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-lg font-light mb-4 text-gray-900 dark:text-white">Safety Profile Summary</h3>
                    <p class="text-sm text-gray-600 dark:text-gray-400 leading-relaxed">
                        The complete absence of immunogenicity over 52 weeks is particularly impressive for a novel engineered 
                        protein therapeutic, validating the adnectin-albumin fusion design. Safety profile essentially mirrors 
                        placebo aside from expected mild injection reactions and common viral symptoms. The lack of any 
                        treatment-related serious adverse events, liver/muscle effects, or neurocognitive signals positions 
                        lerodalcibep's safety on par with or slightly better than first-generation mAbs.
                    </p>
                </div>
            </div>

            <!-- Regulatory Tab -->
            <div id="regulatory" class="tab-content hidden">
                <div class="glass rounded-xl p-6 mb-6 border border-gray-200 dark:border-gray-700">
                    <div class="flex items-center gap-4 mb-6">
                        <span class="inline-flex items-center px-4 py-2 rounded-full text-sm font-medium bg-gradient-to-r from-amber-500 to-orange-500 text-white">
                            FDA Fast Track Designation Granted
                        </span>
                    </div>

                    <div class="relative pl-8">
                        <!-- Timeline line -->
                        <div class="absolute left-3 top-0 bottom-0 w-0.5 bg-gradient-to-b from-transparent via-indigo-300 dark:via-indigo-600 to-transparent"></div>
                        
                        <!-- Timeline items -->
                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-indigo-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-indigo-600 dark:text-indigo-400 mb-1">PRE-2020</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">Technology Acquisition</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    LIB Therapeutics acquired adnectin platform from BMS and optimized the molecule
                                </div>
                            </div>
                        </div>

                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-indigo-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-indigo-600 dark:text-indigo-400 mb-1">2020-2022</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">Phase 2 Development</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    Demonstrated up to 70% LDL-C reduction. 300 mg dose selected.
                                </div>
                            </div>
                        </div>

                        <div class="relative mb-8">
                            <div class="absolute -left-5 w-4 h-4 bg-green-500 rounded-full border-2 border-white dark:border-gray-900"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-indigo-600 dark:text-indigo-400 mb-1">MARCH 2024</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">LIBerate-HR Results</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    52-week data presented at ACC 2024. Co-primary endpoints met.
                                </div>
                                <a href="https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/03/02/05/14/liberate-hr" target="_blank" class="text-xs text-indigo-600 dark:text-indigo-400 hover:underline mt-2 inline-block">
                                    View Presentation â†’
                                </a>
                            </div>
                        </div>

                        <div class="relative">
                            <div class="absolute -left-5 w-4 h-4 bg-amber-500 rounded-full border-2 border-white dark:border-gray-900 animate-pulse"></div>
                            <div class="ml-6 p-4 bg-white dark:bg-gray-800 rounded-lg shadow-md">
                                <div class="text-xs font-medium text-indigo-600 dark:text-indigo-400 mb-1">2024-2025 (PROJECTED)</div>
                                <div class="text-sm font-medium text-gray-900 dark:text-white mb-2">FDA/EMA Submissions</div>
                                <div class="text-xs text-gray-600 dark:text-gray-400">
                                    BLA filing expected. Fast Track should expedite review to potential 2025 approval.
                                </div>
                            </div>
                        </div>
                    </div>
                </div>

                <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-lg font-light mb-4 text-gray-900 dark:text-white">Regulatory Resources</h3>
                    <div class="grid grid-cols-1 md:grid-cols-2 gap-4">
                        <a href="https://www.fda.gov/drugs/development-approval-process-drugs/fast-track" target="_blank" class="p-4 bg-white dark:bg-gray-800 rounded-lg border border-gray-200 dark:border-gray-700 hover:shadow-md transition-shadow">
                            <div class="text-sm font-medium text-gray-900 dark:text-white mb-1">FDA Fast Track Program</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400">Learn about expedited review process</div>
                        </a>
                        <a href="https://www.ema.europa.eu/en" target="_blank" class="p-4 bg-white dark:bg-gray-800 rounded-lg border border-gray-200 dark:border-gray-700 hover:shadow-md transition-shadow">
                            <div class="text-sm font-medium text-gray-900 dark:text-white mb-1">EMA Updates</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400">Check European regulatory status</div>
                        </a>
                    </div>
                </div>
            </div>

            <!-- Commercial Tab -->
            <div id="commercial" class="tab-content hidden">
                <div class="grid grid-cols-1 md:grid-cols-2 gap-6 mb-6">
                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light mb-4 text-gray-900 dark:text-white">Market Advantages</h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2 mt-0.5">âœ“</span>
                                Monthly dosing offers sweet spot between Q2W mAbs and biannual inclisiran
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2 mt-0.5">âœ“</span>
                                Can be distributed through specialty pharmacy (pharmacy benefit)
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2 mt-0.5">âœ“</span>
                                Expected to price ~20% below existing mAbs to drive adoption
                            </li>
                            <li class="flex items-start">
                                <span class="text-green-500 mr-2 mt-0.5">âœ“</span>
                                1.2 mL injection volume more comfortable than larger injections
                            </li>
                        </ul>
                    </div>

                    <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                        <h3 class="text-lg font-light mb-4 text-gray-900 dark:text-white">Commercial Challenges</h3>
                        <ul class="space-y-2 text-sm text-gray-600 dark:text-gray-400">
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2 mt-0.5">!</span>
                                Entering crowded market with established competitors
                            </li>
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2 mt-0.5">!</span>
                                May need big pharma partner for scale
                            </li>
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2 mt-0.5">!</span>
                                Oral PCSK9 inhibitors coming by 2027
                            </li>
                            <li class="flex items-start">
                                <span class="text-amber-500 mr-2 mt-0.5">!</span>
                                No CV outcomes data yet (class effect assumed)
                            </li>
                        </ul>
                    </div>
                </div>

                <div class="glass rounded-xl p-6 border border-gray-200 dark:border-gray-700">
                    <h3 class="text-lg font-light mb-4 text-gray-900 dark:text-white">Market Analysis Resources</h3>
                    <div class="grid grid-cols-1 md:grid-cols-3 gap-4">
                        <a href="https://www.evaluate.com/thought-leadership/pharma/evaluatepharma-world-preview-2024" target="_blank" class="p-4 bg-white dark:bg-gray-800 rounded-lg border border-gray-200 dark:border-gray-700 hover:shadow-md transition-shadow">
                            <div class="text-sm font-medium text-gray-900 dark:text-white mb-1">Market Analysis</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400">PCSK9 market projections</div>
                        </a>
                        <a href="https://www.libtherapeutics.com/investors/" target="_blank" class="p-4 bg-white dark:bg-gray-800 rounded-lg border border-gray-200 dark:border-gray-700 hover:shadow-md transition-shadow">
                            <div class="text-sm font-medium text-gray-900 dark:text-white mb-1">Investor Relations</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400">LIB Therapeutics updates</div>
                        </a>
                        <a href="https://www.fiercepharma.com/search?search=lerodalcibep" target="_blank" class="p-4 bg-white dark:bg-gray-800 rounded-lg border border-gray-200 dark:border-gray-700 hover:shadow-md transition-shadow">
                            <div class="text-sm font-medium text-gray-900 dark:text-white mb-1">Industry News</div>
                            <div class="text-xs text-gray-600 dark:text-gray-400">Latest coverage</div>
                        </a>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <!-- JavaScript -->
    <script>
        function toggleTheme() {
            document.body.classList.toggle('dark');
            localStorage.setItem('theme', document.body.classList.contains('dark') ? 'dark' : 'light');
        }

        // Load saved theme or default to light
        if (localStorage.getItem('theme') === 'dark' || (!localStorage.getItem('theme') && window.matchMedia('(prefers-color-scheme: dark)').matches)) {
            document.body.classList.add('dark');
        }

        function showTab(tabName) {
            // Hide all tab contents
            const tabs = document.querySelectorAll('.tab-content');
            tabs.forEach(tab => {
                tab.classList.add('hidden');
            });
            
            // Show selected tab
            const selectedTab = document.getElementById(tabName);
            if (selectedTab) {
                selectedTab.classList.remove('hidden');
            }
            
            // Update button states
            const buttons = document.querySelectorAll('.tab-btn');
            buttons.forEach(btn => {
                btn.classList.remove('bg-white', 'dark:bg-gray-800', 'text-indigo-600', 'dark:text-indigo-400', 'shadow-md');
                btn.classList.add('text-gray-600', 'dark:text-gray-400');
            });
            
            // Active button state
            event.target.classList.add('bg-white', 'dark:bg-gray-800', 'text-indigo-600', 'dark:text-indigo-400', 'shadow-md');
            event.target.classList.remove('text-gray-600', 'dark:text-gray-400');
        }
    </script>
</body>
</html>